reticulin has been researched along with Thrombocythemia in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andraos, R; Baffert, F; Cozens, R; Dammassa, E; Dölemeyer, A; Ebel, N; Evrot, E; Hofmann, F; Murakami, M; Qian, Z; Radimerski, T; Roelli, C; Romanet, V; Sterker, D | 1 |
Lev, PR; Marta, RF; Molinas, FC; Vassallu, P | 1 |
Birgegård, G; Engström-Laurent, A; Hultdin, M; Lundström, B; Samuelsson, J; Sundström, G; Wahlin, A | 1 |
Choi, E; del Castillo, J; Hunt, P; Kaufman, S; Kinstler, O; Kirley, T; Senaldi, G; Sheridan, WP; Tarpley, J; Ulich, TR; Yin, S | 1 |
Brockschmidt, JK; Buss, DH; O'Connor, ML; Richards, F; Woodruff, RD | 1 |
2 trial(s) available for reticulin and Thrombocythemia
Article | Year |
---|---|
Variation of PDGF, TGFbeta, and bFGF levels in essential thrombocythemia patients treated with anagrelide.
Topics: Adolescent; Adult; Aged; Bone Marrow; Female; Fibroblast Growth Factor 2; Fibrosis; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Count; Platelet-Derived Growth Factor; Quinazolines; Reticulin; Thrombocytosis; Transforming Growth Factor beta | 2002 |
Progression of bone marrow fibrosis in patients with essential thrombocythemia and polycythemia vera during anagrelide treatment.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Disease Progression; Female; Fibrinolytic Agents; Humans; Hyaluronic Acid; Male; Middle Aged; Polycythemia Vera; Primary Myelofibrosis; Prognosis; Prospective Studies; Quinazolines; Reticulin; Thrombocythemia, Essential; Thrombocytosis | 2007 |
3 other study(ies) available for reticulin and Thrombocythemia
Article | Year |
---|---|
JAK1/2 and Pan-deacetylase inhibitor combination therapy yields improved efficacy in preclinical mouse models of JAK2V617F-driven disease.
Topics: Acetylation; Animals; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Cells; Disease Models, Animal; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; Hydroxamic Acids; Indoles; Janus Kinase 1; Janus Kinase 2; Mice; Nitriles; Panobinostat; Polycythemia Vera; Primary Myelofibrosis; Pyrazoles; Pyrimidines; Reticulin; Spleen; Splenomegaly; STAT5 Transcription Factor; Thrombocytosis | 2013 |
Systemic hematologic effects of PEG-rHuMGDF-induced megakaryocyte hyperplasia in mice.
Topics: Anemia; Animals; Bone Marrow; Cell Count; Cell Differentiation; Hematopoietic Stem Cells; Humans; Hyperplasia; Injections, Intraperitoneal; Megakaryocytes; Mice; Mice, Inbred BALB C; Polyethylene Glycols; Primary Myelofibrosis; Recombinant Fusion Proteins; Recombinant Proteins; Reticulin; Splenomegaly; Thrombocytosis; Thrombopoietin | 1996 |
Bone marrow and peripheral blood findings in patients with extreme thrombocytosis. A report of 63 cases.
Topics: Bone Marrow; Cell Aggregation; Humans; Iron; Megakaryocytes; Platelet Aggregation; Reticulin; Retrospective Studies; Thrombocytosis | 1991 |